High CDC20 expression promotes aneuploid cancer cell sensitivity to spindle assembly checkpoint (SAC) inhibition by ...

VANCOUVER, BC, CANADA, January 20, 2025 /EINPresswire / -- The MRD Testing market is expected to grow from an estimated USD 1351.5 million in 2024 to USD 3901.1 million in 2033, at a CAGR of 12.50%.

Morphological profiling allows accurate identification of cell types in dense iPSC-derived cultures, allowing its use for quality control and differentiation monitoring.